Patents by Inventor Aqeel Fatmi

Aqeel Fatmi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquisoft capsules
    Patent number: 11872307
    Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: January 16, 2024
    Assignee: PATHEON SOFTGELS INC.
    Inventors: YinYan Zhao, Yunhua Hu, Mervin Williams, Jr., Tatyana Dyakonov, Saujanya Gosangari, Chue Yang, Henricus Marinus Gerardus Maria Van Duijnhoven, Martin Piest, Aqeel A. Fatmi
  • Fumarate ester dosage forms
    Patent number: 11590095
    Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: February 28, 2023
    Assignee: BANNER LIFE SCIENCES LLC
    Inventors: Jason M. Vaughn, Justin R. Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • LIQUISOFT CAPSULES
    Publication number: 20220211616
    Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.
    Type: Application
    Filed: March 25, 2022
    Publication date: July 7, 2022
    Inventors: YinYan Zhao, Yunhua Hu, Mervin Williams, JR., Tatyana Dyakonov, Saujanya Gosangari, Chue Yang, Henricus Marinus, Gerardus, Maria Van Duijnhoven, Martin Piest, Aqeel A. Fatmi
  • LIQUID DOSAGE FORMS OF SODIUM NAPROXEN
    Publication number: 20210338616
    Abstract: Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the pharmaceutical composition comprises sodium naproxen, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of naproxen, polyethylene glycol, and one or more solubilizers such as propylene glycol, polyvinyl pyrrolidone or a combination thereof.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 4, 2021
    Inventors: Nachiappan CHIDAMBARAM, Aqeel A. FATMI
  • Liquid dosage forms of sodium naproxen
    Patent number: 11090280
    Abstract: Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the pharmaceutical composition comprises sodium naproxen, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of naproxen, polyethylene glycol, and one or more solubilizers such as propylene glycol, polyvinyl pyrrolidone or a combination thereof.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: August 17, 2021
    Assignee: PATHEON SOFTGELS INC.
    Inventors: Nachiappan Chidambaram, Aqeel A. Fatmi
  • FUMARATE ESTER DOSAGE FORMS
    Publication number: 20210161852
    Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
    Type: Application
    Filed: January 13, 2021
    Publication date: June 3, 2021
    Inventors: Jason M. Vaughn, Justin R. Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • Fumarate ester dosage forms
    Patent number: 10945985
    Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: March 16, 2021
    Assignee: BANNER LIFE SCIENCES LLC
    Inventors: Jason M. Vaughn, Justin R. Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • Fumarate ester pharmaceutical compositions
    Patent number: 10918616
    Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: February 16, 2021
    Assignee: BANNER LIFE SCIENCES LLC
    Inventors: Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • Fumarate esters
    Patent number: 10918615
    Abstract: Described herein are pharmaceutical compositions comprising one or more fumarate esters, processes for making the same, and compositions and methods for treating multiple sclerosis subjects with the compositions. In particular, oral pharmaceutical compositions comprising fumarate esters in liquid vehicles are described. One embodiment is an oral delayed release pharmaceutical dosage form comprising a soft capsule encapsulating an immediate releasing liquid comprising one or more fumarate esters.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: February 16, 2021
    Assignee: BANNER LIFE SCIENCES LLC
    Inventors: Jason M. Vaughn, Justin R. Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • Fumarate ester pharmaceutical compositions
    Patent number: 10918617
    Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: February 16, 2021
    Assignee: BANNER LIFE SCIENCES LLC
    Inventors: Tatyana Dyakonov, Sunil Agnihotri, Aqeel A. Fatmi
  • ABUSE-DETERRENT COMPOSITIONS
    Publication number: 20200368169
    Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.
    Type: Application
    Filed: August 11, 2020
    Publication date: November 26, 2020
    Inventors: Saujanya Gosangari, Justin Hughey, Tatyana Dyakonov, George VAMVAKAS, Aqeel A. FATMI
  • Opioid abuse-deterrent controlled release formulations
    Patent number: 10772841
    Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: September 15, 2020
    Assignee: PATHEON SOFTGELS INC.
    Inventors: Saujanya Gosangari, George Vamvakas, Tatyana Dyakonov, Aqeel Fatmi
  • Abuse-deterrent opioids
    Patent number: 10772842
    Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: September 15, 2020
    Assignee: PATHEON SOFTGELS INC.
    Inventors: Saujanya Gosangari, Justin Hughey, Tatyana Dyakonov, George Vamvakas, Aqeel A. Fatmi
  • LIQUISOFT CAPSULES
    Publication number: 20200121595
    Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Inventors: YinYan Zhao, Yunhua Hu, Mervin Williams, JR., Tatyana Dyakonov, Saujanya Gosangari, Chue Yang, Henricus Marinus, Gerardus, Maria Van Duijnhoven, Martin Piest, Aqeel A. Fatmi
  • Liquisoft capsules
    Patent number: 10555901
    Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: February 11, 2020
    Assignee: PATHEON SOFTGELS INC
    Inventors: YinYan Zhao, Yunhua Hu, Mervin Williams, Jr., Tatyana Dyakonov, Saujanya Gosangari, Chue Yang, Henricus Marinus Gerardus Maria Van Duijnhoven, Martin Piest, Aqeel A Fatmi
  • Enteric soft capsules comprising polyunsaturated fatty acids
    Patent number: 10188624
    Abstract: Described herein are pharmaceutical compositions comprising polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules comprising omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and high triglyceride levels.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: January 29, 2019
    Assignee: Patheon Softgels Inc.
    Inventors: Peijin Zhang, Aqeel A. Fatmi
  • Enhanced bioavailability of polyunsaturated fatty acids
    Patent number: 10188623
    Abstract: Described herein are pharmaceutical compositions providing enhanced bioavailability of polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules that provide enhanced bioavailability of omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and moderate to high triglyceride levels.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: January 29, 2019
    Assignee: Patheon Signals Inc.
    Inventors: Peijin Zhang, Aqeel A. Fatmi
  • Silk-based capsules
    Patent number: 10182991
    Abstract: A hard or soft capsule is disclosed comprising a shell and a fill material, wherein the shell comprises an interpenetrating network comprising a silk polymer and a film-forming natural polymer. A method of making a hard or soft capsule is also disclosed, comprising dissolving a silk protein in a solvent system to form a solubilized silk protein solution; mixing the solubilized silk protein solution with a film-forming natural polymer to form a homogenous shell material; and encapsulating a fill material with the homogenous shell material.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: January 22, 2019
    Assignee: Patheon Softgels Inc.
    Inventors: Tatyana Dyakonov, Derek Bush, Saujanya L. Gosangari, Chue Hue Yang, Shingai Majuru, Aqeel Fatmi
  • Compositions for colonic delivery of drugs
    Patent number: 10182993
    Abstract: Described herein are controlled release oral pharmaceutical compositions for delivering active pharmaceutical ingredients to the colon and methods for making the same. In particular, an oral pharmaceutical composition comprising a soft capsule and a controlled release matrix for delivering active pharmaceutical ingredients to the colon are described.
    Type: Grant
    Filed: April 5, 2016
    Date of Patent: January 22, 2019
    Assignee: Patheon Softgels Inc.
    Inventors: Chue Hue Yang, Tatyana Dyakonov, George Vamvakas, Aqeel A. Fatmi
  • Abuse-deterrent controlled release formulations
    Patent number: 10182992
    Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: January 22, 2019
    Assignee: Patheon Softgels Inc.
    Inventors: George Vamvakas, Aqeel A Fatmi